Taw qhia
Kev tshawb fawb metabolic tso siab rau cov cuab yeej loj hlob ntawm cov khoom siv me me ntawm cov khoom siv me me uas tsom mus rau kev sib txawv ntawm lub zog homeostasis. Ntawm cov no, SLU-PP-332 sawv tawm rau nws qhov tshwj xeeb ntawm kev ua raws li lub lauj kaub-ERR agonist thiab tawm dag zog mimetic. Tab sis nws zoo li cas piv rau ntau cov kev tshawb fawb metabolic xws li GLP-1 receptor agonists, AMPK activators, thiab SIRT1 modulators?
Kab lus no piv SLU-PP-332 nrog rau lwm cov chav kawm loj ntawm cov kev tshawb fawb metabolic, qhia txog qhov sib txawv ntawm cov txheej txheem, cov teebmeem tseem ceeb, thiab kev tshawb fawb siv cov ntaub ntawv.
Tsis lees paub: Tag nrho cov tebchaw sib tham yog cov tshuaj tshawb fawb rau kev sim siv xwb. Tsis yog rau tib neeg noj lossis siv tshuaj kho mob.
Dab tsi ua rau SLU-PP-332 txawv?
Lub ntsiab lus txhais ntawm SLU-PP-332 yog nws lub hom phiaj: cov tshuaj estrogen-related receptor (ERR) tsev neeg ntawm cov khoom siv hluav taws xob. Tsis yog ua haujlwm ntawm cov cell nto receptors, enzymes, lossis cov khoom noj khoom haus sensors,SLU-PP-332ncaj qha nkag mus rau hauv lub nucleus thiab reprograms noob qhia txog kev ua haujlwm mitochondrial thiab oxidative metabolism.
Cov lus hauv qab no qhia txog qhov sib txawv tseem ceeb ntawm cov chav kawm metabolic tseem ceeb:
| Compound Class | Lub Hom Phiaj | Mechanism | Cov teebmeem Metabolic |
|---|---|---|---|
| SLU-PP-332 (ERR agonist) | ERR / ERR / ERR nuclear receptors | Transcriptional activation ntawm oxidative metabolism hauv noob | Mitochondrial biogenesis, oxidative fiber hloov, endurance li, nce rog oxidation |
| GLP-1 receptor agonists | GLP-1 receptor (GPCR) | Activates GLP-1 signaling hauv pancreas, hlwb, plab | Txo kev noj zaub mov kom zoo, txhim kho insulin tso tawm, poob phaus |
| AMPK activators | AMP-activated protein kinase | Activates cellular zog sensor kinase | Ntxiv qabzib uptake, txhim kho fatty acid oxidation, suppressed gluconeogenesis |
| SIRT1 activators | Sirtuin 1 (NAD+-dependent deacetylase) | Deacetylates metabolic transcription yam tseem ceeb | Txhim kho insulin rhiab heev, tswj mitochondrial, kev ua neej ntev -txoj kev cuam tshuam |
| PPAR agonists | PPAR / PPAR / PPARδ nuclear receptors | Activates peroxisome proliferator-activated receptors | Lipid txo qis (PPAR), insulin rhiab heev (PPAR), oxidative metabolism (PPARδ) |
Nyob rau hauv luv luv, SLU-PP-332 nyob rau hauv ib tug tshwj xeeb niche: nws yog ib tug ntawm ob peb cov kev tshawb fawb tebchaw uas ncaj qha tsav ib tug endurance ce zoo li transcriptional program ntawm ERR ua kom.
SLU-PP-332 vs GLP-1 Receptor Agonists
GLP-1 receptor agonists yog cov tshuaj tiv thaiv kab mob metabolic uas tseem ceeb tshaj plaws niaj hnub no, siv dav hauv kev kho mob ntshav qab zib thiab rog. Hauv kev tshawb fawb, lawv yog cov cuab yeej siv rau kev kawm gut-brain metabolic signaling.
Mechanism txawv
GLP-1 agonists ua rau G-protein coupled receptor (GLP-1R) qhia nyob rau hauv pancreas, hypothalamus, thiab kab mob plab. Lawv cov teebmeem tseem ceeb yog kho los ntawm txoj hauv kev hormonal thiab neuronal, txo qis qab los noj mov thiab txhim kho cov tshuaj insulin.
SLU-PP-332 ua intracellularly ntawm nuclear receptors, ncaj qha tswj mitochondrial thiab cov leeg nqaij metabolic gene qhia. Nws tsis cuam tshuam rau kev qab los noj mov lossis pancreatic hormone secretion.
Kev Tshawb Fawb Siv Case Txawv
Siv GLP-1 agonists thaum kawm txog kev noj qab haus huv cov cai, incretin physiology, pancreatic beta-kev ua haujlwm ntawm tes, lossis txoj hauv kev poob phaus. Siv SLU-PP-332 thaum kawm mitochondrial biogenesis, skeletal leeg oxidative muaj peev xwm, kev tawm dag zog, lossis ERR signaling biology.
Key Takeaway
SLU-PP-332 thiab GLP-1 agonists ua haujlwm los ntawm txoj kev sib txawv kiag li thiab daws cov lus nug sib txawv. Lawv yog cov sib ntxiv ntau dua li cov cuab yeej sib tw, thiab qee qhov kev tshawb fawb tshawb nrhiav kev sib xyaw ua ke ntawm kev noj qab haus huv tag nrho.
Rau qhov tob tob rau hauv qhov SLU-PP-332 ua haujlwm li cas ntawm qib molecular, saib peb tsab xov xwm tag nrho ntawmSLU-PP-332 mechanism ntawm kev txiav txim.
SLU-PP-332 vs AMPK Activators
AMPK yog lub npe hu ua "cellular zog sensor." Cov activators zoo li AICAR thiab metformin tau siv dav hauv kev tshawb fawb metabolic.
Mechanism txawv
AMPK activators ua rau kinase cascade hauv cov lus teb rau cov xov tooj ntawm tes tsis muaj zog (siab AMP / ATP piv). AMPK phosphorylation tom qab ntawd hloov cov haujlwm ntawm kaum ob ntawm cov enzymes hauv qab thiab cov khoom siv hloov pauv, suav nrog kev txhawb nqa kev ua haujlwm ntawm mitochondrial.
SLU-PP-332 ua ncaj qha rau ntawm qib transcriptional ntawm ERRs, hla kev nkag mus rau hauv dej ntws. Nws tsis tas yuav muaj lub zog tsis txaus los qhib cov kev pabcuam mitochondrial.
Kev ua haujlwm txawv
AMPK activation acutely nce qabzib uptake thiab fatty acid oxidation, thiab suppresses anabolic txoj kev. SLU-PP-332 tsav qhov dav thiab ntau dua kev hloov pauv kev hloov pauv ntawm mitochondrial biogenesis thiab oxidative fiber remodelling, ntau ze ze rau kev ua haujlwm ntev ntev.
Kev Tshawb Fawb Siv Case Txawv
Siv AMPK activators rau kev kawm txog kev hnov mob lub zog, qabzib homeostasis, thiab enzyme- theem kev tswj hwm metabolic. Siv SLU-PP-332 los kawm txog kev hloov pauv hloov pauv ntawm oxidative metabolism, nqaij fiber ntau phenotype, thiab endurance adaptation.
SLU-PP-332 vs PPAR Agonists
PPARs yog cov receptors nuclear, zoo li ERRs, thiab PPAR agonists (fibrates, thiazolidinediones) muaj keeb kwm ntev hauv kev tshawb fawb metabolic thiab kev siv tshuaj kho mob.
Mechanism txawv
PPAR agonists tsom rau peroxisome proliferator-activated receptors, uas tswj cov lipid metabolism, adipocytes sib txawv, thiab insulin rhiab heev. PPARδ agonists tshwj xeeb kuj txhim kho oxidative metabolism hauv cov leeg.
SLU-PP-332 lub hom phiaj ERRs, uas muaj feem cuam tshuam nrog PPARs thiab qhia qee lub hom phiaj, tab sis muaj kev tsom mus rau mitochondrial biogenesis thiab ua pa ua haujlwm. ERRs kuj cuam tshuam nrog PGC-1 ua coactivators.
Kev ua haujlwm txawv
PPAR agonists ua kom cov insulin rhiab heev tab sis tuaj yeem ua rau qhov hnyav nce thiab adipogenesis. PPARδ agonists txhim kho endurance thiab rog oxidation, nrog cov teebmeem ib nrab sib tshooj nrog ERR agonists. SLU-PP-332 nthuav tawm cov mitochondrial biogenesis thiab oxidative fiber hloov pauv, nrog rau kev cuam tshuam tsawg dua ntawm adipocytes sib txawv piv rau PPAR .
Kev Tshawb Fawb Siv Case Txawv
Siv PPAR agonists rau kev kawm adipogenesis, lipid metabolism, thiab txoj hauv kev rhiab heev rau insulin. Siv SLU-PP-332 ua ib qho cuab yeej xaiv ntau dua rau kev kawm ERR-specific mitochondrial thiab kev tawm dag zog txoj hauv kev.
SLU-PP-332 vs SIRT1 Activators
Sirtuin activators (piv txwv li, resveratrol analogs) tau kawm txog cov teebmeem metabolic thiab kev ua neej ntev.
Mechanism txawv
SIRT1 activators txhawb kev ua haujlwm ntawm SIRT1, NAD+- nyob ntawm deacetylase uas hloov cov haujlwm ntawm PGC-1 , FOXO, thiab lwm yam kev tswj hwm cov metabolism. Lawv cov teebmeem ntawm mitochondria yog qhov tsis ncaj thiab nyob ntawm cellular NAD + xwm txheej.
SLU-PP-332 ncaj qha khi thiab qhib ERR receptors, ua haujlwm qis ntawm SIRT1/PGC-1 kev cai. Nws cov teebmeem yog ncaj qha thiab tsawg dua nyob ntawm cellular metabolic xeev.
Kev Tshawb Fawb Siv Case Txawv
Siv SIRT1 activators rau kev kawm NAD + biology, txoj kev laus, thiab kev paub txog zaub mov. Siv SLU-PP-332 rau kev ua kom ncaj, muaj zog ntawm ERR-mediated oxidative gene program.
Kev Tshawb Fawb Qhov Zoo ntawm ERR Ua Haujlwm Nrog SLU-PP-332
Muab ntau yam ntawm cov cuab yeej metabolic, vim li cas cov kws tshawb fawb tau tig mus rau SLU-PP-332?
Direct Transcriptional Control ntawm Mitochondrial FunctionSLU-PP-332 muab ncaj qha, tshuaj tswj kev tswj hwm ERR, tus tswv tswj hwm ntawm mitochondrial biogenesis. Qhov no ua rau nws yog ib qho cuab yeej huv rau kev kawm txog kev sib raug zoo ntawm mitochondrial gene qhia thiab metabolic phenotypes.
Unique Exercise Mimetic ProfileOb peb lub tebchaw rov tsim dua cov qauv tshwj xeeb ntawm cov leeg pob txha oxidative adaptation induced los ntawm endurance kev cob qhia. SLU-PP-332 yog ib qho ntawm cov qauv me me uas zoo tshaj plaws rau cov phenotype no.
Qhov txawv ntawm cov chav kawm tshuaj kho mobFeem ntau cov tshuaj metabolic tam sim no tsom GLP-1, insulin, lossis AMPK txoj hauv kev. ERR agonism sawv cev rau ib qho tshiab, tsis siv cov txheej txheem rau tom ntej -kev tshawb nrhiav tshuaj, ua rau SLU-PP-332 yog ib qho tseem ceeb soj ntsuam rau cov kev tshawb fawb tshiab.
Orally Bioavailable thiab Cell -PermeableSLU-PP-332 ua haujlwm tau zoo nyob rau hauv ob qho tib si kab lis kev cai ntawm tes thiab qhov ncauj noj tsiaj qauv, muab kev yooj yim ntawm kev sim tshuab.
Kev Tshawb Fawb Kev Sib Tw TsawgPiv nrog rau cov hom phiaj tau kawm hnyav xws li GLP-1 thiab AMPK, ERR-kev tawm dag zog ua kom sib haum xeeb sawv cev rau thaj chaw tshawb fawb tshiab nrog tsawg dua cov kev tshawb fawb luam tawm thiab qhib kev tshawb pom ntau dua. Rau cov chaw sim nrhiav kom paub qhov txawv ntawm lawv cov kev tshawb fawb, SLU-PP-332 muaj kev nkag mus rau qhov loj hlob sai tab sis tseem tsis tau txaus.
Kev taw qhia yav tom ntej ntawm Exercise Mimetic Research
Raws li kev tshawb fawb metabolic hloov zuj zus mus, kev tawm dag zog mimetics tau muab tso rau los ua ib qho ntawm cov cuab yeej muaj txiaj ntsig zoo tshaj plaws hauv kev laus biology, kev tshawb fawb sarcopenia, thiab kev tshawb pom cov tshuaj metabolic. Ob peb lub ntsiab lus tseem ceeb yog tsim cov theem tom ntej ntawm daim teb no:
Kev Tshawb Fawb Kev Sib TxuasKev tshawb fawb ntau ntxiv yog tshawb nrhiav ERR agonists ua ke nrog lwm cov tshuaj metabolic modulators - suav nrog AMPK activators, PPAR agonists, thiab GLP-1 pathway compounds - los tshawb xyuas cov teebmeem ntawm kev ua siab ntev, insulin rhiab heev, thiab lub cev muaj pes tsawg leeg. SLU-PP-332 ua haujlwm raws li kev sojntsuam zoo tshaj plaws rau cov kev tshawb fawb ua ke no vim nws qhov ua tau zoo ERR yam ntxwv thiab cov txiaj ntsig pharmacokinetic profile.
Cov ntaub so ntswg-Specific ERR BiologyCov kws tshawb fawb tau nthuav tawm ntau lub luag haujlwm ntawm ERR , ERR , thiab ERR hauv cov leeg pob txha, plawv, siab, cov ntaub so ntswg adipose, thiab lub hlwb. SLU-PP-332's yias-ERR kev ua haujlwm muab cov cuab yeej hauv paus, thaum cov agonists tshiab subtype-selective agonists tseem tshwm sim nrog nws rau kev tshawb nrhiav ntau dua.
Daim ntawv thov kev laus thiab kev ua neej ntevMitochondrial poob yog qhov cim ntawm kev laus. ERR agonism tau raug kawm raws li lub tswv yim los khaws cov kev ua haujlwm mitochondrial hauv cov ntaub so ntswg hnub nyoog, tswj cov leeg nqaij thiab kev ua siab ntev, thiab ncua hnub nyoog - cuam tshuam txog metabolic deterioration. Cov kab no ntawm kev tshawb fawb txoj haujlwm SLU-PP-332 yog ib qho khoom muaj txiaj ntsig zoo rau cov chaw soj ntsuam geroscience.
Kev Txhais Tshuaj Txhim KhoRaws li cov ntaub ntawv pov thawj preclinical rau ERR- cov txiaj ntsig metabolic tau nce ntxiv, cov tuam txhab biotech tab tom nce qib kev xaiv ERR agonists mus rau thaum ntxov - theem tshuaj txhim kho. SLU-PP-332 tseem yog cov ntaub ntawv pov thawj kev sib xyaw ua ke hauv cov raj xa dej no, siv rau kev kuaj xyuas qhov tseeb, hauv vivo pov thawj- ntawm- lub tswv yim, thiab kev tshawb fawb txog kev sib raug zoo ntawm cov qauv.
Rau kev nthuav dav dav ntawm kev tshawb fawb toj roob hauv pes hloov zuj zus, saib peb 2026 SLU-PP-332 kev ua lag luam thiab tsab ntawv tshaj tawm kev tshawb fawb.
fAQ
Q: Puas yog SLU-PP-332 zoo dua AICAR rau kev tshawb fawb txog kev ua siab ntev?
A: Nws nyob ntawm cov lus nug tshawb fawb. AICAR yog ib qho AMPK activator uas txhawb nqa lub zog metabolism, thaum SLU-PP-332 ua los ntawm ERRs los tsav cov kev pabcuam dav dav ntawm mitochondrial biogenesis thiab oxidative fiber hloov. Rau cov kev tshawb fawb tsom tshwj xeeb ntawm kev tawm dag zog thiab cov leeg nqaij fiber ntau phenotype, SLU-PP-332 muaj qhov ncaj qha thiab txhawb nqa zoo li profile. Rau cov kev tshawb fawb pom lub zog, AICAR yuav tsim nyog dua.
Q: SLU-PP-332 puas tuaj yeem siv ua ke nrog lwm cov tshuaj metabolic?
A: Yog lawm, SLU-PP-332 feem ntau yog siv rau hauv kev tshawb fawb ua ke nrog AMPK activators, PPAR agonists, thiab lwm yam kev sojntsuam metabolic los tshawb xyuas txoj hauv kev crosstalk thiab muaj peev xwm ua kom muaj txiaj ntsig zoo. Nws orthogonal mechanism ua rau nws zoo haum rau kev sib xyaw ua ke kev sim tsim.
Q: Puas yog SLU-PP-332 ua rau poob phaus zoo li GLP-1 agonists?
A: GLP-1 agonists feem ntau tsav qhov hnyav los ntawm kev noj qab haus huv. SLU-PP-332 tsis muaj feem cuam tshuam rau kev noj zaub mov. Hauv cov qauv preclinical, nws tuaj yeem txhawb nqa lub cev muaj txiaj ntsig zoo hloov pauv ntawm kev nce oxidative metabolism thiab thermogenesis, tab sis nws qhov hnyav hnyav yog feem ntau me me thiab sib txawv ntawm GLP-1 txoj hauv kev sib txuas.
Q: Puas yog SLU-PP-332 yog PPAR agonist?
A: Tsis yog. SLU-PP-332 yog ERR (estrogen-related receptor) agonist. ERRs thiab PPARs yog cov tsev neeg muaj feem cuam tshuam nrog cov tsev neeg muaj zog nuclear thiab qhia qee cov noob caj noob ces, tab sis lawv yog cov hom phiaj sib txawv nrog cov ntawv sib txawv thiab kev ua haujlwm lom neeg.
Q: Lub ntsiab lus twg yog qhov zoo tshaj plaws rau kev kawm mitochondrial biogenesis?
A: SLU-PP-332 yog ib qho ntawm cov khoom siv hluav taws xob ncaj qha thiab muaj zog tshaj plaws rau inducing mitochondrial biogenesis ntawm ERR / PGC-1 txoj kev ua kom muaj zog. AMPK activators thiab SIRT1 modulators kuj txhawb nqa kev ua haujlwm mitochondrial tab sis ua tsis ncaj los ntawm txoj kev nkag mus rau lub zog.
Q: Qhov twg metabolic compound feem ntau zoo li kev ua kom muaj zog?
A: Ntawm cov kev tshawb fawb tshawb fawb dav dav, SLU-PP-332 feem ntau zoo rov qab sau cov npe kos npe ntawm kev ua kom muaj zog hauv cov leeg pob txha. AMPK activators ua raws li lub zog hnyav ntawm kev tawm dag zog, thaum SLU-PP-332 rov ua dua qhov kev hloov pauv mus sij hawm ntev mitochondrial thiab cov leeg nqaij fiber ntau.
Q: Puas yog SLU-PP-332 haum rau kev tshawb fawb kev laus thiab kev ua neej ntev?
A: Yog, SLU-PP-332 tau siv ntau ntxiv hauv kev tshawb fawb txog kev tshawb fawb los kawm txog hnub nyoog txog kev poob qis, sarcopenia, thiab poob ntawm metabolic yooj. Nws lub peev xwm los txhawb kev ua haujlwm mitochondrial ua rau nws muaj txiaj ntsig zoo rau kev tshawb nrhiav kev cuam tshuam uas khaws cov metabolism hauv kev laus.
Cov ntaub ntawv tshawb fawb
Nwachukwu JC, et al. Discovery of SLU-PP-332, yias-Estrogen-Related Receptor Agonist Uas Txhim Kho Metabolic Fitness.Cell Chemical Biology. 2022.
Eichner LJ, Giguère V. Estrogen-txog receptors ua tus tswj hwm ntawm mitochondrial biogenesis thiab kev ua haujlwm.Trends hauv Endocrinology & Metabolism. 2011.
Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, lub zog homeostasis, thiab metabolism.Kev tshuaj xyuas endocrine. 2006.
Drucker DJ. Biology ntawm glucagon-zoo li peptide-1 thiab nws cov receptors.Nature Reviews Endocrinology. 2018.
Richter EA, Hargreaves M. Exercise, GLUT4, thiab skeletal leeg qabzib uptake.Kev tshuaj xyuas lub cev. 2013.
Qhov Chaw Tshawb Fawb -Qib SLU-PP-332 rau Kev Sib Piv Metabolic Studies
HDM BIO muab kev tshawb fawb-qib SLU-PP-332 hmoov txheeb xyuas los ntawm HPLC thiab LC-MS, nrog rau tag nrho cov ntaub ntawv -COA tshwj xeeb. Raws li Tuam Tshoj-based chaw tsim tshuaj paus tshwj xeeb hauv cov cuab yeej metabolic biology sib txuas, peb xa cov khoom zoo ib yam, tus nqi sib tw, thiab kev xa khoom thoob ntiaj teb rau kev kawm thiab biopharma pab pawg tshawb fawb.
Txawm hais tias koj tab tom ua cov txheej txheem - ntawm - kev tshawb fawb txog kev ua, kev sim ua ke, lossis kev tshuaj ntsuam xyuas tshuaj, peb SLU-PP-332 yog tsim los pab txhawb kev tsim tawm, kev tshawb fawb zoo.
Txhawm rau saib cov lus qhia tshwj xeeb lossis thov kev tsocai, mus saib peb SLU-PP-332 Powder Supplier Tuam Tshoj nplooj ntawv khoom.